Carevive Systems, Inc.
15
2
3
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.7%
1 terminated/withdrawn out of 15 trials
91.7%
+5.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Role: lead
Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring
Role: lead
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy
Role: collaborator
Improving Supportive Care For Patients With Thoracic Malignancies
Role: collaborator
Enhancing Shared Decision-Making in Breast Cancer
Role: collaborator
Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia
Role: lead
Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.
Role: lead
Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL
Role: lead
Shared Decision Making in Pain Management Planning in Patients With Cancer
Role: lead
Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans
Role: lead
Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study
Role: lead
Understanding Evidence-Based Practice Patterns in Advanced NSCLC
Role: lead
Metastatic Breast Cancer Treatment Planning
Role: lead
Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning
Role: lead
Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma
Role: lead
All 15 trials loaded